NCT00093977 Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease Status COMPLETED Phase PHASE3
NCT00093873 Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00093015 Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT) Status COMPLETED Phase PHASE3
NCT00091858 Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer Status COMPLETED Phase PHASE3
NCT00091832 Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00091806 Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00091793 Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis Status COMPLETED Phase PHASE3
NCT00089960 Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) Status COMPLETED Phase PHASE2
NCT00089791 A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis Status COMPLETED Phase PHASE3
NCT00089674 AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer Status COMPLETED Phase PHASE3
NCT00089661 AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00089635 Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00086086 Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia Status COMPLETED Phase PHASE2
NCT00083616 Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy Status COMPLETED Phase PHASE2
NCT00079612 Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer Status COMPLETED Phase PHASE2
NCT00078806 Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis Status TERMINATED Phase PHASE3
NCT00078793 Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT00073307 Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer Status COMPLETED Phase PHASE3
NCT00072319 Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer Status COMPLETED Phase PHASE2